标题
In vivo hematopoietic stem cell modification by mRNA delivery
作者
关键词
-
出版物
SCIENCE
Volume 381, Issue 6656, Pages 436-443
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2023-07-28
DOI
10.1126/science.ade6967
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CAR T cells produced in vivo to treat cardiac injury
- (2022) Joel G. Rurik et al. SCIENCE
- Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathies
- (2021) Laura Breda et al. MOLECULAR THERAPY
- Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
- (2021) István Tombácz et al. MOLECULAR THERAPY
- Base editing of haematopoietic stem cells rescues sickle cell disease in mice
- (2021) Gregory A. Newby et al. NATURE
- Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier
- (2020) Oscar A. Marcos-Contreras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipid nanoparticles for nucleic acid delivery: Current perspectives
- (2020) Eleni Samaridou et al. ADVANCED DRUG DELIVERY REVIEWS
- Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation
- (2019) Agnieszka Czechowicz et al. Nature Communications
- Low Exposure Busulfan Conditioning to Achieve Sufficient Multi-lineage Chimerism in Patients with Severe Combined Immunodeficiency
- (2019) Christopher C. Dvorak et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
- (2019) Markus Baiersdörfer et al. Molecular Therapy-Nucleic Acids
- MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct
- (2018) Ruchi Jain et al. Nucleic Acid Therapeutics
- PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
- (2018) Hamideh Parhiz et al. JOURNAL OF CONTROLLED RELEASE
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers
- (2016) L. Breda et al. BLOOD
- Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?
- (2016) Marina Cavazzana et al. HUMAN GENE THERAPY
- mRNA: Fulfilling the Promise of Gene Therapy
- (2015) Drew Weissman et al. MOLECULAR THERAPY
- Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
- (2013) Martin A Maier et al. MOLECULAR THERAPY
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- The human stem cell hierarchy is defined by a functional dependence on Mcl-1 for self-renewal capacity
- (2010) C. J. V. Campbell et al. BLOOD
- Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease
- (2010) M. Andreani et al. HAEMATOLOGICA
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
- (2010) Akin Akinc et al. MOLECULAR THERAPY
- Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential
- (2009) D. G. Kent et al. BLOOD
- A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
- (2009) Linda Madisen et al. NATURE NEUROSCIENCE
- Endocrinological late complications after hematopoietic SCT in children
- (2008) A Cohen et al. BONE MARROW TRANSPLANTATION
- Regulation of Hematopoietic Stem Cells by the Steel Factor/KIT Signaling Pathway
- (2008) D. Kent et al. CLINICAL CANCER RESEARCH
- In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of -thalassemia
- (2008) A. Miccio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now